New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 7, 2014
06:20 EDTGHDXGenomic Health downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse downgraded Genomic Health citing lack of catalysts. Price target lowered to $29 from $36.
News For GHDX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2015
08:23 EDTGHDXGenomic Health's Oncotype DX shows increase in prostate cancer surveillance
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use